Episode
Joel Latham: Building Incannex & Betting on the Future of Biotech
- Podcast
- Legends N Leaders
- Published
- Jul 27, 2026
- Duration seconds
- 1160
- Processing state
not_requested
Actions
POST https://stenobird.com/v1/public/podcasts/legends-n-leaders-6687872/episodes/joel-latham-building-incannex-betting-on-the-future-of-biotech/transcription-requests
Idempotently request low-priority transcript generation for this episode.GET https://stenobird.com/podcast/legends-n-leaders-6687872/joel-latham-building-incannex-betting-on-the-future-of-biotech.md
Read the agent-friendly Markdown representation of this episode resource.
Summary
Joel Latham, CEO of Incannex, joins LegendsNLeaders to share his journey building and leading a biotechnology company focused on developing new therapies for major unmet medical needs. Joel takes us through his path to Incannex, the challenges of building a biotech company, and what it takes to move new treatments from an idea through development and toward commercialization. In this episode, Joel discusses the realities of the biotech industry, raising capital, navigating clinical development and regulation, building a public company, and making long-term bets in an industry where breakthroughs can take years to develop. He also shares the pivotal moments that shaped his career, lessons from leading Incannex, and his perspective on the future of biotechnology and pharmaceutical innovation. #JoelLatham #Incannex #Biotech #Biotechnology #Pharmaceuticals #Healthcare #HealthTech #CEO #Leadership #Entrepreneurship #ClinicalTrials